Cambridge Biomarketing’s Jordan Tavenner Named A 2016 PM360 ELITE 100 Disrupter

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge BioMarketing, the world’s leading rare disease and specialty commercialization agency, today announced that Art Director Jordan Tavenner has been named a “Disrupter” in the 2016 PM360 ELITE 100. The award, which recognizes fearless individuals who help revolutionize their field, honors the smartest and most accomplished professionals in pharma marketing for their boundless creativity, transformative work, and ability to shape the future of the industry.

“His ability to marry creativity with the technical, medical-oriented aspects of rare diseases and translate these concepts into emotionally engaging and compelling campaigns is truly remarkable.”

“Jordan possesses an uncommon level of creativity, digital savvy, and strategic foresight, which is a rare combination of competencies and qualities that his colleagues and clients deeply admire and appreciate,” said Alisa Shakarian, Creative Director, Art, Cambridge BioMarketing. “His ability to marry creativity with the technical, medical-oriented aspects of rare diseases and translate these concepts into emotionally engaging and compelling campaigns is truly remarkable.”

Among his many achievements, Tavenner launched Intercept LivingwithPBC.com, an award-winning, online resource for people diagnosed with primary biliary cholangitis (PBC), as conveyed through the experiences of patients living with the disease. The website provides patients with a forum to discuss their disease and connect with others who face similar issues.

With more than 10 years of creative and digital design experience, Tavenner embodies the type of individual Cambridge BioMarketing retains and nurtures to develop professional skills and deliver high-impact results to clients. The agency continues to distinguish itself with some of the industry’s top talent and through imaginative and emotionally compelling campaigns that showcase inspiring stories of patients living with rare diseases.

The PM360 ELITE (Exceptional Leaders, Innovators, Transformers and Entrepreneurs) 100 honors individuals across 16 categories, including “Disrupters,” “Creative Directors,” and “Digital Crusaders.” Now in its second year, the list received nearly twice as many submissions as last year, a testament to the robust competition and level of talent inherent within this space.

The 100 individuals will be formally recognized on July 12, 2016 at the Top of the Standard Hotel in Manhattan’s Meatpacking District.

About Cambridge BioMarketing
Cambridge BioMarketing is a rare disease and specialty market agency, blending medical insights and award-winning creativity with deep experience to build some of the world’s most successful brands. With solutions for our clients that empower, educate, and activate, we bring physicians, specialists, and patient communities together to transform human health in the face of devastating, under-appreciated disease states. Founded in 2001, Cambridge BioMarketing is headquartered in Cambridge, MA, and is a division of Everyday Health, Inc. For more information, visit: www.cambridgebmg.com.

About Everyday Health
Everyday Health, Inc. (NYSE: EVDY) is a leading provider of digital health marketing and communications solutions. Everyday Health attracts a large and engaged audience of consumers and healthcare professionals to its premier health and wellness properties, and utilizes its data and analytics expertise to deliver highly personalized content experiences and efficient and effective marketing and engagement solutions. Everyday Health enables consumers to manage their daily health and wellness needs, healthcare professionals to stay informed and make better decisions for their patients, and marketers, health payers and providers to communicate and engage with consumers and healthcare professionals to drive better health outcomes. Everyday Health's content and solutions are delivered through multiple channels, including desktop, mobile web, and mobile phone and tablet applications, as well as video and social media.